Back

A well-defined subgroup of chronic thromboembolic pulmonary hypertension patients are positive for antiphospholipid antibodies

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Chronic venous thromboembolism Pathophysiology and Mechanisms ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Zhi-Cheng Jing

Guangdong Provincial People's Hospital, Guangzhou (China)

10 More presentations in this session

Presentation thumbnail
Long-term changes of exercise haemodynamics and physical capacity in chronic thromboembolic pulmonary hypertension after pulmonary thromboendarterectomy
Doctor F. Waziri (Herning, DK)
Abstract
Presentation thumbnail
Current outcome of chronic thromboembolic pulmonary hypertension in Spain
Doctor P. Martinez Santos (Madrid, ES)
Abstract
Presentation thumbnail
Macitentan in chronic thromboembolic pulmonary hypertension (CTEPH): combined data from OPUS and OrPHeUS real-world data sets
Professor R. Channick (Los Angeles, US)
Abstract
Presentation thumbnail
Implementation of the new chronic thromboembolic pulmonary hypertension treatment algorithm: an ongoing effort from a portuguese referral centre
Doctor S. Alegria (Almada, PT)
Abstract
Presentation thumbnail
The utility of additional balloon pulmonary angioplasty for residual hypoxemia in normohemodynamic chronic thromboembolic pulmonary hypertension patients after invasive treatments.
Doctor H. Shimokawahara (Okayama, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Chronic venous thromboembolism

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources